Point mutation in a 3' flanking sequence of the alpha-1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence

Hum Mol Genet. 1993 Mar;2(3):253-7. doi: 10.1093/hmg/2.3.253.

Abstract

A point mutation in the 3' flanking sequence of the alpha-1-antitrypsin gene is associated with chronic respiratory disease. This study demonstrates that the mutation occurs in a motif that binds a nuclear factor. A direct consequence of the mutation is the loss of specific binding. Functional studies with constructs containing this region downstream of a reporter gene in the sense orientation demonstrated that the wild type sequence increased expression compared with control promoter plasmid and there was a significant reduction in expression by the mutant sequence. These effects were demonstrated in three distinct cell lines suggesting an ubiquitous rather than a tissue-specific effect. However, transacting factors may influence the response in different tissues. The mutation does not appear to affect basal expression of the protein as the plasma concentration of alpha-1-antitrypsin is normal in individuals who carry the mutation. However, the binding and functional studies suggest that it may reduce the three- to four-fold rise in plasma alpha-1-antitrypsin concentration that occurs during inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Chronic Disease
  • DNA / genetics
  • Enhancer Elements, Genetic
  • Humans
  • Molecular Sequence Data
  • Point Mutation*
  • Regulatory Sequences, Nucleic Acid*
  • Respiratory Tract Diseases / genetics*
  • alpha 1-Antitrypsin / genetics*

Substances

  • alpha 1-Antitrypsin
  • DNA